CRISPR Therapeutics' Q1 Loss Wider Than Expected, Sales Miss Estimates
5/5 14:19
CRSP posts a wider Q1 loss and revenues miss, pressuring shares, even as Casgevy sales grow and cash reserves strengthen from recent financing....
5/5 14:19
CRSP posts a wider Q1 loss and revenues miss, pressuring shares, even as Casgevy sales grow and cash reserves strengthen from recent financing....